Inventor
ROEHLE KEVIN
DE11 patents
Patents
11 patentsUS11214608B2Jan 4, 2022
Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH6 citations85
US11248035B1Feb 15, 2022
Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH3 citations84
US11078253B2Aug 3, 2021
Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH5 citations84
US11053296B2Jul 6, 2021
Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH5 citations84
US12065477B2Aug 20, 2024
Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US11919940B2Mar 5, 2024
Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US11858978B2Jan 2, 2024
Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US11840562B2Dec 12, 2023
Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US11345737B1May 31, 2022
Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US10899820B2Jan 26, 2021
Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations59
US10781244B2Sep 22, 2020
Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations49